Autonomix Medical, Inc. (AMIX) stock
AMIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$1.08−0.02 (-1.82%)
Close on Nov 17, 2026Market cap $1.05MP/E –Yield –
Autonomix Medical r&d expenses
Research and development expenses are spending on new products and technology.
Autonomix Medical's R&D Expenses for the twelve months ending Jun 30, 2026 was $7.07M, up 31.7% year over year. For fiscal 2026 it was $7.14M, up 51.2% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $7.14M | +51.2% |
| FY2025 | Mar 31, 2025 | $4.73M | +112.4% |
| FY2024 | Mar 31, 2024 | $2.23M | +198.7% |
| FY2023 | Mar 31, 2023 | $745.00K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $1.52M | -4.9% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $1.46M | -6.0% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $1.72M | +65.1% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $2.37M | +101.6% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $1.59M | +67.0% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $1.55M | +122.5% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $1.04M | +52.0% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $1.17M | +149.3% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $954.00K | +159.2% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $698.00K | +71.5% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $687.00K | +245.2% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $471.00K | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $368.00K | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $407.00K | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $199.00K | – |
See a number that looks wrong?